Hemapoeitic differentiation and therapeutic potential of uniparent parthenogenetic embryonal stem cells
- Authors: Lopatina T.
- Issue: Vol 2, No 2 (2007)
- Pages: 14-15
- Section: Cell transplant
- URL: https://genescells.ru/2313-1829/article/view/217688
- ID: 217688
Cite item
Open Access
Access granted
Full Text
About the authors
T. Lopatina
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation
References
- Mann J.R., Gadi I., Нarbison M.L., Abbondanzo S.J. Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic imprinting. Cell 1990; 62(2): 251-60.
- Stevens L.C., Varnum D.S., Eicher E.M.. Viable chimaeras produced from normal and parthenogenetic mouse embryos. Nature 1977; 269: 515-7.
- Surani M.A., Вarton S.C., Kaufman M.Н. Development to term of chimaeras between diploid parthenogenetic and fertilised embryos. Nature 1977; 270: 601-3.
- Kennedy M., Keller G.M. Нematopoietic commitment of ES cells in culture. Methods Enzymol. 2003; 365: 39-59.
Supplementary files
